Position in BIIB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$83,037,475
+$13,047,948 QoQ
Shares Held
384,326
+0.7% QoQ
Ownership
0.260%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#48
of 1,036 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $1,583,496,479 across 9 Drug Manufacturers - General names. BIIB ranks #7 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
401,970 | $482,134,917 | |
| 2 | ABBV |
AbbVie Inc.
|
1,164,745 | $293,096,431 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,419,478 | $182,402,923 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
1,191,380 | $150,518,949 | |
| 5 | AMGN |
Amgen Inc
|
362,985 | $131,444,128 | |
| 6 | JNJ |
Johnson & Johnson
|
510,174 | $129,568,890 | |
| 7 | BIIB |
Biogen Inc.
This page
|
384,326 | $83,037,475 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,196,072 | $68,917,668 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83,037,475 | 384,326 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $69,989,527 | 381,768 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $58,159,767 | 330,472 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $22,247,645 | 158,821 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $20,510,730 | 163,315 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $25,558,975 | 186,780 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $30,884,334 | 201,964 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $41,182,664 | 212,457 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $61,770,525 | 266,459 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $57,582,266 | 267,042 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $47,946,199 | 185,285 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $60,129,802 | 233,959 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $66,625,560 | 233,897 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $83,060,072 | 298,745 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $82,470,375 | 297,813 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $67,059,453 | 251,159 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $51,432,240 | 252,193 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $51,188,436 | 243,060 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $52,273,049 | 217,877 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $77,155,242 | 272,643 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $95,238,100 | 275,040 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $109,345,882 | 390,870 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $95,708,428 | 390,870 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $104,277,647 | 367,589 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $91,212,878 | 340,919 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $124,737,560 | 394,265 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||